PharmCube

PharmCube, a China-based data & media company, was founded in 2013 with a mission to uncover trends in the Chinese pharmaceutical industry. The company serves as a one-stop pharma data intelligence platform, aiming to connect the industry chain with data intelligence and improve industry efficiency. With a focus on creating an ecosystem for the healthcare industry, PharmCube has garnered a strong presence, engaging over 100,000 professional users in the pharmaceutical sector. The company's operations include monitoring drug data in China, the United States, the European Union, Japan, and other mainstream global markets, enabling them to grasp real-time trends. PharmCube has established a unique and systematic drug data standard, collaborating with regulatory officials and traditional data companies to become a connection center and industry leader. They have systematically collected, cleaned, and transformed massive drug data, integrating it into a data warehouse, and developed a comprehensive big data framework. In 23 November 2021, PharmCube secured a CNY100.00M Venture Round investment from Wind, further boosting its position in the pharmaceutical data industry. With a focus on health care and pharmaceuticals, PharmCube is positioned as an agile and professional drug big data monitoring platform, striving for ongoing evolution and expansion in its data warehouse and monitoring projects.